Planet 13 Holdings PLNH
OTC PLNH
$0.16 +0.01 (+5.63%)
As of: Aug 21, 2026 · 3:59 PM EDT

Planet 13 Holdings (PLNH) Asset Writedowns and Impairment (2021 - 2025)

Planet 13 Holdings (PLNH) posted quarterly Asset Writedowns and Impairment of $11.7 million for Q4 2025, up 1284.67% year-over-year from $846449.0 in Q4 2024, and up 100.01% quarter-over-quarter from $5.9 million in Q3 2025.

Planet 13 Holdings (PLNH) Asset Writedowns and Impairment (2021 - 2025) Analysis & Trends

Planet 13 Holdings (PLNH) has reported Asset Writedowns and Impairment for 5 consecutive years, with $11.7 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Asset Writedowns and Impairment rose 1284.67% year-over-year to $11.7 million; the TTM figure through Dec 2025 stood at $20.1 million (down 59.33% YoY), while the FY2025 annual figure was $17.6 million, up 442.69% from the prior year.
  • Asset Writedowns and Impairment advanced to $11.7 million in Q4 2025 per PLNH's latest filing, from $5.9 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $46.8 million in Q4 2023 and bottomed at -$3.3 million in Q4 2021.
  • Historically, Asset Writedowns and Impairment has averaged $5.7 million across 5 years, with a median of $950585.0 in 2022.
  • Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment plunged 162.1% — and 2025, when it soared 1284.67%.
  • Planet 13 Holdings' Asset Writedowns and Impairment stood at -$3.3 million in 2021, then soared by 308.46% to $6.9 million in 2022, then surged by 574.27% to $46.8 million in 2023, then slumped by 98.19% to $846449.0 in 2024, then jumped by 1284.67% to $11.7 million in 2025.
  • Business Quant data shows PLNH's Asset Writedowns and Impairment at $11.7 million in Q4 2025, $5.9 million in Q3 2025, and $846449.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Planet 13 Holdings 52.64 Mn 36.16 Mn 12.32 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 11.72 Mn
Dec 31, 2025 11.72 Mn
Sep 30, 2025 5.86 Mn
Sep 30, 2025 5.86 Mn
Dec 31, 2024 846,449.00
Dec 31, 2024 846,449.00
Sep 30, 2024 1.63 Mn
Sep 30, 2024 1.63 Mn
Dec 31, 2023 46.85 Mn
Dec 31, 2023 46.85 Mn
Dec 31, 2022 6.95 Mn
Dec 31, 2022 6.95 Mn
Sep 30, 2022 -1.80 Mn
Sep 30, 2022 -1.80 Mn
Jun 30, 2022 849,008.00
Jun 30, 2022 849,008.00
Mar 31, 2022 950,585.00
Mar 31, 2022 950,585.00
Dec 31, 2021 -3.33 Mn
Dec 31, 2021 -3.33 Mn